119
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Lower Levels of Circulating Adiponectin in Elderly Patients with Metabolic Inflammatory Syndrome: A Cross-Sectional Study

ORCID Icon, , , &
Pages 591-596 | Published online: 28 Feb 2020

References

  • The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014;2(8):634–647. doi:10.1016/S2213-8587(14)70102-0
  • Esser N, Legrand-Poels S, Piette J, et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105(2):141–150. doi:10.1016/j.diabres.2014.04.006
  • Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–867. doi:10.1038/nature05485
  • Hu R, Xie Y, Lu B, et al. Metabolic inflammatory syndrome: a novel concept of holistic integrative medicine for management of metabolic diseases. AME Med J. 2018;3:51. doi:10.21037/amj
  • Hu R. Concept and clinical significance of metabolic inflammatory syndrome. Clin Focus. 2016;31(9):960–963.
  • Li R, Hu R. Progress in the pathogenesis of metabolic inflammatory syndrome. Fudan Univ J Med Sci. 2017;44(3):380–384.
  • Hu R, Xie Y, Lu B, et al. High detective rate of “metabolic inflammatory syndrome” in patients with type 2 diabetes. Chin J Endocrinol Metab. 2016;32:27–32.
  • Adiyaman SC, Ozer M, Saydam BO, et al. The role of adiponectin in maintaining metabolic homeostasis. Curr Diabetes Rev. 2019. doi:10.2174/1573399815666190702155733
  • Lara-Castro C, Fu Y, Chung BH, et al. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol. 2007;18:263–270. doi:10.1097/MOL.0b013e32814a645f
  • Shih CH, Hsu BG, Hou JS, et al. Association of low serum adiponectin levels with aortic arterial stiffness in patients with type 2 diabetes. J Clin Med. 2019;8(6):E887. doi:10.3390/jcm8060887
  • Yanai H, Yoshida H. Beneficial Effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives. Int J Mol Sci. 2019;20(5):E1190. doi:10.3390/ijms20051190
  • Esfahani M, Movahedian A, Baranchi M, et al. Adiponectin: an adipokine with protective features against metabolic syndrome. Iran J Basic Med Sci. 2015;18(5):430–442.
  • Hung WC, Wang CP, Lu LF, et al. Circulating adiponectin level is associated with major adverse cardiovascular events in type 2 diabetic patients with coronary artery disease. Endocr J. 2010;(57):793–802. doi:10.1507/endocrj.K10E-020
  • Schottker B, Herder C, Rothenbacher D, et al. Proinflammatory cytokines, adiponectin, and increased risk of primary cardiovascular events in diabetic patients with or without renal dysfunction: results from the ESTHER study. Diabetes Care. 2013;36(6):1703–1711. doi:10.2337/dc12-1416
  • Schulze MB, Shai I, Rimm EB, et al. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes. 2005;54:534–539. doi:10.2337/diabetes.54.2.534
  • Krzyzanowska K, Aso Y, Mittermayer F, et al. High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes. Transl Res. 2009;153(4):199–203. doi:10.1016/j.trsl.2009.01.009
  • Woodward L, Akoumianakis I, Antoniades C. Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease. Br J Pharmacol. 2017;174(22):4007–4020. doi:10.1111/bph.v174.22
  • Krause MP, Milne KJ, Hawke TJ. Adiponectin-consideration for its role in skeletal muscle health. Int J Mol Sci. 2019;20(7):E1528. doi:10.3390/ijms20071528
  • Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 2008;14:222–231. doi:10.2119/2007-00119.Tilg
  • Nguyen MT, Fernando S, Schwarz N, et al. Inflammation as a therapeutic target in atherosclerosis. J Clin Med. 2019;8(8):E1109. doi:10.3390/jcm8081109
  • Komohara Y, Fujiwara Y, Ohnishi K, et al. Contribution of macrophage polarization to metabolic diseases. J Atheroscler Thromb. 2016;23(1):10–17. doi:10.5551/jat.32359
  • Fang H, Judd RL. Adiponectin regulation and function. Compr Physiol. 2018;8(3):1031–1063.
  • Knights AJ, Funnell AP, Pearson RC, Crossley M, Bell-Anderson KS. Adipokines and insulin action –A sensitive issue. Landes Biosci. 2014;3(4–6):88–96.
  • Hector J, Schwarzloh B, Goehring J, et al. TNF-alpha alters visfatin and adiponectin levels in human fat. Horm Metab Res. 2007;39:250–255. doi:10.1055/s-2007-973075
  • Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACR P30. Nat Med. 2002;8:731–737. doi:10.1038/nm724